<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01583868</url>
  </required_header>
  <id_info>
    <org_study_id>755E</org_study_id>
    <nct_id>NCT01583868</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate the Product Feasibility of Two New Silicone Hydrogel Contact Lenses</brief_title>
  <official_title>A Study to Evaluate the Product Feasibility of Two New Silicone Hydrogel Contact Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bausch &amp; Lomb Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bausch &amp; Lomb Incorporated</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to determine the clinical feasibility and to evaluate the&#xD;
      product performance of two RD2135-01 investigational soft contact lenses (Test 1 and Test 2)&#xD;
      developed by Bausch + Lomb. The Test lenses will be compared to both Bausch + Lomb&#xD;
      PureVisionÂ®2 HD (high definition) soft contact lenses and Ciba Vision Air Optix Aqua soft&#xD;
      contact lenses when used among currently adapted soft contact lens wearers.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">July 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Acuity</measure>
    <time_frame>At 1 week follow up</time_frame>
    <description>Visual acuity was assessed by distance high contrast logarithm of the minimum angle of resolution (logMAR).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Symptoms and Complaints</measure>
    <time_frame>At 1 Week follow up</time_frame>
    <description>Symptoms/complaints were assessed on a scale from 0 to 100, with 0 denoting unfavorable symptoms/complaints. Symptoms/complaints were recorded for each eye based on the participant's experience with their study lenses worn for that respective treatment period. Symptoms/complaints parameters included the following: Burning/stinging upon insertion, Comfort upon insertion, Overall comfort, Comfort at end of day, Ease of handling/insertion, Ease of handling/removal, Dryness, Itchiness, Redness, Vision upon insertion, Vision, Vision in low light, Lens cleanness upon insertion, Lens cleanness upon removal, Lens cleanness, Dryness at end of day, and Overall impression.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">216</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>B&amp;L RD2135-01 lens C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Investigational Silicone hydrogel soft contact lens</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B&amp;L RD2135-01 lens D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Investigational Silicone hydrogel soft contact lens</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PureVision2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bausch &amp; Lomb High definition soft contact lenses</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ciba Vision Air Optix Aqua</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ciba Vision Air Optix Aqua soft contact lens</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>B&amp;L RD2135-01 lens C</intervention_name>
    <description>Lenses will be worn on a daily wear basis for 1 week. Lens care solution and lens cases will be provided for daily rinsing, cleaning, disinfecting, and storing the lenses. Rewetting drops will be provided for use as needed during the study.</description>
    <arm_group_label>B&amp;L RD2135-01 lens C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>B&amp;L RD2135-01 lens D</intervention_name>
    <description>Lenses will be worn on a daily wear basis for 1 week. Lens care solution and lens cases will be provided for daily rinsing, cleaning, disinfecting, and storing the lenses. Rewetting drops will be provided for use as needed during the study.</description>
    <arm_group_label>B&amp;L RD2135-01 lens D</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PureVision2</intervention_name>
    <description>Lenses will be worn on a daily wear basis for 1 week. Lens care solution and lens cases will be provided for daily rinsing, cleaning, disinfecting, and storing the lenses. Rewetting drops will be provided for use as needed during the study.</description>
    <arm_group_label>PureVision2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Air Optix Aqua</intervention_name>
    <description>Lenses will be worn on a daily wear basis for 1 week. Lens care solution and lens cases will be provided for daily rinsing, cleaning, disinfecting, and storing the lenses. Rewetting drops will be provided for use as needed during the study.</description>
    <arm_group_label>Ciba Vision Air Optix Aqua</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Have physiologically normal anterior segments not exhibiting clinically significant&#xD;
             biomicroscopy findings.&#xD;
&#xD;
          -  Be adapted wearers of soft contact lenses, wear a lens in each eye, and each lens must&#xD;
             be of the same manufacture and brand.&#xD;
&#xD;
          -  Be correctable through spherocylindrical refraction to 32 letters (0.3 logMAR) or&#xD;
             better (distance, high contrast) in each eye.&#xD;
&#xD;
          -  Be myopic and require lens correction from -0.50 diopters (D) to -6.00 D in each eye.&#xD;
&#xD;
          -  Must agree to wear the study lenses on a daily wear basis for the duration of the&#xD;
             study.&#xD;
&#xD;
          -  Must be willing to use a lens care system on a regular basis.&#xD;
&#xD;
          -  If the subject requires a Washout Period, the subject must be willing to discontinue&#xD;
             contact lens wear and be willing to wear either spectacles or no lenses during this&#xD;
             Washout Period.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Not correctable to 32 letters (0.3 logMAR) in each eye with soft spherical contact&#xD;
             lenses.&#xD;
&#xD;
          -  Have an active ocular disease, any corneal infiltrative response or are using any&#xD;
             ocular medications.&#xD;
&#xD;
          -  Have worn gas permeable (GP) contact lenses within last 30 days or PMMA lenses within&#xD;
             last 3 months.&#xD;
&#xD;
          -  Any scar or neovascularization within the central 4mm of the cornea.&#xD;
&#xD;
          -  Any Grade 2 or greater finding during the slit lamp examination, Subjects with corneal&#xD;
             infiltrates, of ANY GRADE, are not eligible.&#xD;
&#xD;
          -  Any &quot;Present&quot; finding during the slit lamp examination that, in the Investigator's&#xD;
             judgment, interferes with contact lens wear.&#xD;
&#xD;
          -  Anisometropia (spherical equivalent) of greater than 2.00 D.&#xD;
&#xD;
          -  Any systemic disease affecting ocular health.&#xD;
&#xD;
          -  Using any systemic or topical medications that will affect ocular physiology or lens&#xD;
             performance.&#xD;
&#xD;
          -  Aphakic.&#xD;
&#xD;
          -  Amblyopic.&#xD;
&#xD;
          -  Allergic to any component in the study products.&#xD;
&#xD;
          -  Have had any corneal surgery (ie, refractive surgery).&#xD;
&#xD;
          -  Currently wear monovision correction, multifocal, or toric contact lenses.&#xD;
&#xD;
          -  Ocular astigmatism greater than 1.00 D in either eye.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Beverly J Barna, CCRA</last_name>
    <role>Study Director</role>
    <affiliation>Bausch &amp; Lomb Incorporated</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bausch &amp; Lomb Incorporated</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14609</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>April 23, 2012</study_first_submitted>
  <study_first_submitted_qc>April 23, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 24, 2012</study_first_posted>
  <results_first_submitted>August 21, 2020</results_first_submitted>
  <results_first_submitted_qc>September 29, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">October 22, 2020</results_first_posted>
  <last_update_submitted>September 29, 2020</last_update_submitted>
  <last_update_submitted_qc>September 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>This was a randomized, bilateral, study, with a crossover at one week and a second crossover at two weeks. A total of 216 subjects (432 eyes) were enrolled in this study. Participants were randomized to receive either, the Test Lens C, Test Lens D and PureVision2 lenses, or the Test Lens C, Test Lens D and Air Optix Aqua lenses.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>B&amp;L RD2135-01 Lens C Then B&amp;L RD2135-01 Lens D Then PureVision</title>
          <description>B&amp;L RD2135-01 Lens C for one week then B&amp;L RD2135-01 Lens D for one week then PureVision2 for one week</description>
        </group>
        <group group_id="P2">
          <title>B&amp;L RD2135-01 Lens C Then B&amp;L RD2135-01 Lens D Then Ciba Vis</title>
          <description>B&amp;L RD2135-01 Lens C for one week then B&amp;L RD2135-01 Lens D for one week then Ciba Vision for one week</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="108"/>
                <participants group_id="P2" count="108"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="104"/>
                <participants group_id="P2" count="104"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Demography was collected for 210 eligible, dispensed participants. Participants received multiple treatment groups in this cross-over study. Two participants did not have demography information.</population>
      <group_list>
        <group group_id="B1">
          <title>B&amp;L RD2135-01 Lens C Then B&amp;L RD2135-01 Lens D Then PureVision</title>
          <description>B&amp;L RD2135-01 Lens C for one week then B&amp;L RD2135-01 Lens D for one week then PureVision2 for one week</description>
        </group>
        <group group_id="B2">
          <title>B&amp;L RD2135-01 Lens C Then B&amp;L RD2135-01 Lens D Then Ciba Vis</title>
          <description>B&amp;L RD2135-01 Lens C for one week then B&amp;L RD2135-01 Lens D for one week then Ciba Vision for one week</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="105"/>
            <count group_id="B2" value="105"/>
            <count group_id="B3" value="210"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31.3" spread="8.55"/>
                    <measurement group_id="B2" value="31.8" spread="8.68"/>
                    <measurement group_id="B3" value="31.5" spread="8.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="72"/>
                    <measurement group_id="B2" value="71"/>
                    <measurement group_id="B3" value="143"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Visual Acuity</title>
        <description>Visual acuity was assessed by distance high contrast logarithm of the minimum angle of resolution (logMAR).</description>
        <time_frame>At 1 week follow up</time_frame>
        <population>There were 212 eligible, dispensed participants (424 eyes). Participants/eyes received multiple treatment groups in this cross-over study. All eyes received investigational lens C and investigation lens D. Half of the eyes received PureVision2 and half of the eyes received Ciba Vision Air Optix Aqua.</population>
        <group_list>
          <group group_id="O1">
            <title>B&amp;L RD2135-01 Lens C</title>
            <description>Investigational Silicone hydrogel soft contact lens&#xD;
B&amp;L RD2135-01 lens C: Lenses will be worn on a daily wear basis for 1 week. Lens care solution and lens cases will be provided for daily rinsing, cleaning, disinfecting, and storing the lenses. Rewetting drops will be provided for use as needed during the study.</description>
          </group>
          <group group_id="O2">
            <title>B&amp;L RD2135-01 Lens D</title>
            <description>Investigational Silicone hydrogel soft contact lens&#xD;
B&amp;L RD2135-01 lens D: Lenses will be worn on a daily wear basis for 1 week. Lens care solution and lens cases will be provided for daily rinsing, cleaning, disinfecting, and storing the lenses. Rewetting drops will be provided for use as needed during the study.</description>
          </group>
          <group group_id="O3">
            <title>PureVision2</title>
            <description>Bausch &amp; Lomb High definition soft contact lenses&#xD;
PureVision2: Lenses will be worn on a daily wear basis for 1 week. Lens care solution and lens cases will be provided for daily rinsing, cleaning, disinfecting, and storing the lenses. Rewetting drops will be provided for use as needed during the study.</description>
          </group>
          <group group_id="O4">
            <title>Ciba Vision Air Optix Aqua</title>
            <description>Ciba Vision Air Optix Aqua soft contact lens&#xD;
Air Optix Aqua: Lenses will be worn on a daily wear basis for 1 week. Lens care solution and lens cases will be provided for daily rinsing, cleaning, disinfecting, and storing the lenses. Rewetting drops will be provided for use as needed during the study.</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Acuity</title>
          <description>Visual acuity was assessed by distance high contrast logarithm of the minimum angle of resolution (logMAR).</description>
          <population>There were 212 eligible, dispensed participants (424 eyes). Participants/eyes received multiple treatment groups in this cross-over study. All eyes received investigational lens C and investigation lens D. Half of the eyes received PureVision2 and half of the eyes received Ciba Vision Air Optix Aqua.</population>
          <units>logMAR</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="212"/>
                <count group_id="O2" value="212"/>
                <count group_id="O3" value="106"/>
                <count group_id="O4" value="106"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="424"/>
                <count group_id="O2" value="424"/>
                <count group_id="O3" value="212"/>
                <count group_id="O4" value="212"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.089" spread="0.078"/>
                    <measurement group_id="O2" value="-0.087" spread="0.079"/>
                    <measurement group_id="O3" value="-0.086" spread="0.077"/>
                    <measurement group_id="O4" value="-0.086" spread="0.082"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Symptoms and Complaints</title>
        <description>Symptoms/complaints were assessed on a scale from 0 to 100, with 0 denoting unfavorable symptoms/complaints. Symptoms/complaints were recorded for each eye based on the participant's experience with their study lenses worn for that respective treatment period. Symptoms/complaints parameters included the following: Burning/stinging upon insertion, Comfort upon insertion, Overall comfort, Comfort at end of day, Ease of handling/insertion, Ease of handling/removal, Dryness, Itchiness, Redness, Vision upon insertion, Vision, Vision in low light, Lens cleanness upon insertion, Lens cleanness upon removal, Lens cleanness, Dryness at end of day, and Overall impression.</description>
        <time_frame>At 1 Week follow up</time_frame>
        <population>There were 212 eligible, dispensed participants (424 eyes). Participants/eyes received multiple treatment groups in this cross-over study. All eyes received investigational lens C and investigation lens D. Half of the eyes received PureVision2 and half of the eyes received Ciba Vision Air Optix Aqua.</population>
        <group_list>
          <group group_id="O1">
            <title>B&amp;L RD2135-01 Lens C</title>
            <description>Investigational Silicone hydrogel soft contact lens&#xD;
B&amp;L RD2135-01 lens C: Lenses will be worn on a daily wear basis for 1 week. Lens care solution and lens cases will be provided for daily rinsing, cleaning, disinfecting, and storing the lenses. Rewetting drops will be provided for use as needed during the study.</description>
          </group>
          <group group_id="O2">
            <title>B&amp;L RD2135-01 Lens D</title>
            <description>Investigational Silicone hydrogel soft contact lens&#xD;
B&amp;L RD2135-01 lens D: Lenses will be worn on a daily wear basis for 1 week. Lens care solution and lens cases will be provided for daily rinsing, cleaning, disinfecting, and storing the lenses. Rewetting drops will be provided for use as needed during the study.</description>
          </group>
          <group group_id="O3">
            <title>PureVision2</title>
            <description>Bausch &amp; Lomb High definition soft contact lenses&#xD;
PureVision2: Lenses will be worn on a daily wear basis for 1 week. Lens care solution and lens cases will be provided for daily rinsing, cleaning, disinfecting, and storing the lenses. Rewetting drops will be provided for use as needed during the study.</description>
          </group>
          <group group_id="O4">
            <title>Ciba Vision Air Optix Aqua</title>
            <description>Ciba Vision Air Optix Aqua soft contact lens&#xD;
Air Optix Aqua: Lenses will be worn on a daily wear basis for 1 week. Lens care solution and lens cases will be provided for daily rinsing, cleaning, disinfecting, and storing the lenses. Rewetting drops will be provided for use as needed during the study.</description>
          </group>
        </group_list>
        <measure>
          <title>Symptoms and Complaints</title>
          <description>Symptoms/complaints were assessed on a scale from 0 to 100, with 0 denoting unfavorable symptoms/complaints. Symptoms/complaints were recorded for each eye based on the participant's experience with their study lenses worn for that respective treatment period. Symptoms/complaints parameters included the following: Burning/stinging upon insertion, Comfort upon insertion, Overall comfort, Comfort at end of day, Ease of handling/insertion, Ease of handling/removal, Dryness, Itchiness, Redness, Vision upon insertion, Vision, Vision in low light, Lens cleanness upon insertion, Lens cleanness upon removal, Lens cleanness, Dryness at end of day, and Overall impression.</description>
          <population>There were 212 eligible, dispensed participants (424 eyes). Participants/eyes received multiple treatment groups in this cross-over study. All eyes received investigational lens C and investigation lens D. Half of the eyes received PureVision2 and half of the eyes received Ciba Vision Air Optix Aqua.</population>
          <units>score on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="212"/>
                <count group_id="O2" value="212"/>
                <count group_id="O3" value="106"/>
                <count group_id="O4" value="106"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="424"/>
                <count group_id="O2" value="424"/>
                <count group_id="O3" value="212"/>
                <count group_id="O4" value="212"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Burning/stinging upon insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.3" spread="13.1"/>
                    <measurement group_id="O2" value="91.3" spread="12.4"/>
                    <measurement group_id="O3" value="83.1" spread="21.4"/>
                    <measurement group_id="O4" value="92.6" spread="9.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Comfort upon insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.6" spread="14.5"/>
                    <measurement group_id="O2" value="88.2" spread="15.6"/>
                    <measurement group_id="O3" value="78.7" spread="15.6"/>
                    <measurement group_id="O4" value="89.6" spread="12.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall comfort</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.0" spread="14.6"/>
                    <measurement group_id="O2" value="85.7" spread="16.9"/>
                    <measurement group_id="O3" value="78.4" spread="20.4"/>
                    <measurement group_id="O4" value="86.6" spread="15.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Comfort at end of day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.2" spread="18.9"/>
                    <measurement group_id="O2" value="79.3" spread="20.2"/>
                    <measurement group_id="O3" value="72.0" spread="22.9"/>
                    <measurement group_id="O4" value="79.7" spread="19.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ease of handling/insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.5" spread="16.6"/>
                    <measurement group_id="O2" value="88.6" spread="17.3"/>
                    <measurement group_id="O3" value="85.0" spread="20.4"/>
                    <measurement group_id="O4" value="89.0" spread="15.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ease of handling/removal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.1" spread="14.3"/>
                    <measurement group_id="O2" value="91.0" spread="13.6"/>
                    <measurement group_id="O3" value="89.4" spread="15.6"/>
                    <measurement group_id="O4" value="89.4" spread="15.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dryness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.4" spread="16.1"/>
                    <measurement group_id="O2" value="81.9" spread="18.1"/>
                    <measurement group_id="O3" value="77.0" spread="21.6"/>
                    <measurement group_id="O4" value="84.4" spread="17.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Itchiness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.6" spread="12.9"/>
                    <measurement group_id="O2" value="89.6" spread="15.9"/>
                    <measurement group_id="O3" value="87.4" spread="17.0"/>
                    <measurement group_id="O4" value="88.5" spread="17.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Redness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.4" spread="11.7"/>
                    <measurement group_id="O2" value="91.6" spread="13.1"/>
                    <measurement group_id="O3" value="90.6" spread="14.0"/>
                    <measurement group_id="O4" value="91.2" spread="12.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vision upon insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.4" spread="9.6"/>
                    <measurement group_id="O2" value="91.5" spread="13.3"/>
                    <measurement group_id="O3" value="87.0" spread="17.5"/>
                    <measurement group_id="O4" value="93.1" spread="9.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vision</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.3" spread="11.4"/>
                    <measurement group_id="O2" value="91.9" spread="13.1"/>
                    <measurement group_id="O3" value="88.1" spread="14.6"/>
                    <measurement group_id="O4" value="93.5" spread="10.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vision in low light</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.0" spread="11.9"/>
                    <measurement group_id="O2" value="89.9" spread="13.4"/>
                    <measurement group_id="O3" value="87.3" spread="13.8"/>
                    <measurement group_id="O4" value="91.4" spread="12.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lens cleanness upon insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.1" spread="10.9"/>
                    <measurement group_id="O2" value="92.8" spread="11.4"/>
                    <measurement group_id="O3" value="89.7" spread="14.6"/>
                    <measurement group_id="O4" value="94.4" spread="7.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lens cleannes upon removal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.9" spread="12.2"/>
                    <measurement group_id="O2" value="89.3" spread="12.9"/>
                    <measurement group_id="O3" value="86.3" spread="17.2"/>
                    <measurement group_id="O4" value="90.9" spread="9.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lens cleanness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.8" spread="10.6"/>
                    <measurement group_id="O2" value="91.2" spread="11.7"/>
                    <measurement group_id="O3" value="86.6" spread="17.0"/>
                    <measurement group_id="O4" value="92.5" spread="9.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dryness at end of day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82.4" spread="17.7"/>
                    <measurement group_id="O2" value="80.3" spread="19.3"/>
                    <measurement group_id="O3" value="75.5" spread="21.7"/>
                    <measurement group_id="O4" value="82.4" spread="17.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall impression</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.5" spread="17.0"/>
                    <measurement group_id="O2" value="82.2" spread="19.0"/>
                    <measurement group_id="O3" value="73.7" spread="24.6"/>
                    <measurement group_id="O4" value="83.9" spread="18.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3 weeks</time_frame>
      <desc>Adverse events (AEs) were not coded. Therefore, source vocabulary is not applicable. Safety data were collected for 212 eligible, dispensed participants. Participants received multiple treatment groups in this cross-over study.</desc>
      <group_list>
        <group group_id="E1">
          <title>B&amp;L RD2135-01 Lens C</title>
          <description>B&amp;L RD2135-01 Lens C</description>
        </group>
        <group group_id="E2">
          <title>B&amp;L RD2135-01 Lens D</title>
          <description>B&amp;L RD2135-01 Lens D</description>
        </group>
        <group group_id="E3">
          <title>PureVision2</title>
          <description>PureVision2</description>
        </group>
        <group group_id="E4">
          <title>Ciba Vision Air Optix Aqua</title>
          <description>Ciba Vision Air Optix Aqua</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="212"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="212"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="106"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="212"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="212"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="106"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Contact sponsor directly for details.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Study Director</name_or_title>
      <organization>Bausch Health</organization>
      <email>robert.steffen@bausch.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

